今年A股谁在玩“口号式”回购？

Core Viewpoint - The A-share market in 2023 has seen a significant trend of share buybacks, indicating a strong confidence in the long-term prospects of companies and industries [1] Summary by Sections Overall Market Activity - As of November 17, 2023, 831 companies in the A-share market have conducted share buybacks, with a total amount of 111.06 billion yuan, reflecting a positive sentiment towards the market [1] - 37 companies announced buyback plans but executed less than 0.2% of their proposed buybacks, contrasting sharply with those actively repurchasing shares [1] Notable Companies - Shanzi Gaoke: Announced a buyback plan on July 26, 2024, intending to repurchase shares worth between 600 million and 1 billion yuan, with a target of 179 million to 299 million shares. However, by the end of the buyback period, only 11 million yuan was spent, acquiring 4.83 million shares, far below the planned minimum [2][3] - Hanwujing: Announced a buyback plan on July 27, 2024, with a budget of 2 million to 4 million yuan, aiming to buy back 67,200 to 134,300 shares. The actual buyback amounted to 2.006 million yuan, acquiring only 36,600 shares, significantly below the target [5] Market Manipulation Concerns - Some companies have been accused of using buyback announcements to manipulate market perceptions, attracting investor attention and inflating stock prices without fulfilling their buyback commitments [6][7] High-Value Buybacks - Companies like Guizhou Moutai, Muyuan Foods, Hikvision, and others have executed buybacks exceeding 1 billion yuan, with Guizhou Moutai leading at nearly 6 billion yuan for 3.93 million shares [9][10] Volume of Buybacks - Companies such as Yongtai Energy, Liaogang Co., and others have repurchased over 10 million shares, with Yongtai Energy leading at 400 million shares [11][12] Industry Insights - The pharmaceutical and biotechnology sector has the highest number of companies engaging in buybacks, with 109 companies (12.7% of the total), followed by the electronics sector with 107 companies (12.4%) [16][17] - In the pharmaceutical sector, Jiuzan Medical led in buyback spending at 1.18 billion yuan, while Nengte Technology had the highest volume at 157 million shares [16][17]